Effective antigen presentation by dendritic cells is NF-κB dependent: Coordinate regulation of MHC, co-stimulatory molecules and cytokines

International Immunology

Volumn 13, Issue 5, 2001, Pages 675-683

  Yoshimura, S ^a   Bondeson, J ^a   Foxwell, B M J ^a   Brennan, F M ^a   Feldmann, M ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Adenovirus; Antigen presentation; Dendritic cell; NF B

Indexed keywords

ANTIGEN; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA; VIRUS VECTOR;

ADENOVIRUS; ALLERGY; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; CELL INTERACTION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; GENE TARGETING; GENE TRANSFER; METHODOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSPLANTATION; VIRUS INFECTION;

EID: 0035022325     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/13.5.675     Document Type: Article

References (55)

1. Dendritic cells and the control of immunity
2. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution
3. Dendritic cells induce T cell proliferation to synthetic antigens under Ir gene control
4. Antigen presentation, antigen-presenting cells and antigen processing
5. Isolation and characterization of human peripheral blood dendritic cells
6. Dendritic cell development: Multiple pathways to nature's adjuvants
7. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
8. + dendritic cells
9. + hematopoietic progenitor cells
10. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability
11. Anti-class II MHC antibodies prevent and treat EAE without APC depletion
12. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism
13. Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: Requirement for both B7-1 and B7-2
14. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE
15. Electroporation and DNA-dependent cell death in murine macrophages
16. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
17. Efficient adenoviral infection with IκBα reveals that macrophage tumor necrosis factor a production in rheumatoid arthritis is NF-κB dependent
18. Selective regulation of cytokine induction by adenoviral gene transfer of IκBα into human macrophages: Lipopolysaccharide-induced, but not zymosan-induced, pro-inflammatory cytokines are inhibited, but IL-10 is independent
19. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood
20. A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells
21. Methods for construction of adenovirus vectors
22. Defining therapeutic targets by using adenovirus: Blocking NF-κB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators
23. Interleukin-4 inhibits k light chain expression and NF-κB activation but not IκBα degradation in 70Z/3 murine pre-B cells
24. Identification of novel factors that bind to the PRD I region of the human β-interferon promoter
25. Evaluation of measurement of human TNF in plasma by ELISA
26. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-α antibody with the interleukin-1 receptor antagonist
27. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity
28. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF-α processing in RA synovial membrane cell cultures
29. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
30. Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells
31. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity
32. High efficiency adenovirus-mediated gene transfer to human dendritic cells
33. The dendritic cell system and its role in immunogenicity
34. CD80 (B7) and CD86 (B70) provide similar co-stimulatory signals for T cell proliferation, cytokine production, and generation of CTL
35. Nuclear localization of RelB is associated with effective antigen-presenting cell function
36. Expression of relB transcripts during lymphoid organ development: Specific expression in dendritic antigen-presenting cells
37. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still, bound to NF-kappa B
38. Effect of proteasome inhibitors on monocytic IkappaB-alpha and -beta depletion, NF-kappaB activation, and cytokine production
39. Role of NF-κB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteosome inhibitor PSI
40. An essential role for NF-κB in preventing TNF-α-induced cell death
41. Suppression of TNF-α-induced apoptosis by NF-κB
42. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
43. + T cells
44. + T cells
45. Expression of ICAM-3 on human epidermal dendritic cells
46. The Rel subunit of NF-κB-like transcription factors is a positive and negative regulator of macrophage gene expression: Distinct roles for Rel in different macrophage populations
47. Upon dendritic cell (DC) activation chemokines and chemokines receptor expression are rapidly regulated for recruitment and maintenance of DC at the inflammatory site
48. Expression of relB is required for the development of thymic medulla and dendritic cells
49. Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture
50. Burnet Oration: Dendritic cells: Multiple subtypes multiple origins, multiple functions
51. The control of T cell responses by dendritic cell subsets
52. T cell activation determined by T cell receptor number and tunable thresholds
53. Danger - Pathogen on the premises! Immunological tolerance
54. The role of self-recognition in receptor repertoire development
55. Tolerance, danger, and the extended family